Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
XIIDRA (Shire Australia Pty Ltd)
Product name
XIIDRA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
216 working days (255)
Active ingredients
lifitegrast
Registration type
NCE/NBE
Indication
XIIDRA (eye drops) is indicated for the treatment of moderate to severe dry eye disease in adults for whom prior use of artificial tears has not been sufficient.